Kardigan Quarterly Cash Flow Statement
NASDAQ: KARDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
14.67+0.47 (+3.31%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Kardigan cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q? 20262026-03-31 | Q? 20252025-06-30 | Q? 20252025-03-31 |
|---|---|---|---|---|
| Net Income | -116.24M | -56.07M | -57.45M | -18.02M |
| Net Income growth (YoY) | — | — | — | — |
| Depreciation & Amortization | 400.00K | — | 100.00K | — |
| Stock-Based Compensation | 11.70M | — | 18.65M | — |
This table shows 4 quarterly periods of Kardigan's cash flow statement, from Q2 2026 back to Q? 2025, across 3 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow KARD's reporting calendar. What is a cash flow statement?